NanoSmart Pharmaceuticals Receives Patent Allowance for Tumor Targeting Platform Technology

NanoSmart Pharmaceuticals, Inc., a California corporation developing novel biopharmaceuticals, is pleased to report that it has received a Notice of Allowance for a US patent on its proprietary cancer tumor targeting technology.

Related Posts

Comments are closed.